Noninvasive assessment of coronary artery disease: The role of stress echocardiography

Italian Heart Journal

Volumn 2, Issue 4, 2001, Pages 250-255

  Cortigiani, L ^a   Desideri, A ^a   Bigi, R ^a  

^a CAMPO DI MARTE HOSPITAL   (Italy)

Author keywords

Dipyridamole; Dobutamine; Exercise test; Ischemic heart disease; Stress echocardiography

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELECTROCARDIOGRAM; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART RUPTURE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; HYPOTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; PACEMAKER; PHARMACOLOGY; PREDICTION; PROGNOSIS; SAFETY; STRESS; STRESS ECHOCARDIOGRAPHY; WORKLOAD;

CORONARY DISEASE; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; EXERCISE; HUMANS; HYPERTENSION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0035009755     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Pathogenetic mechanisms of stress
2. Exercise cross-sectional echocardiography in ischemic heart disease
3. High dose dipyridamole echocardiography test in effort angina pectoris
4. Echocardiographic detection of coronary artery disease during dobutamine infusion
5. Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography
6. Exercise echocardiography: Detection of coronary artery disease in patients with normal left ventricular motion at rest
7. Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography
8. Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary arteriography
9. Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: Comparison and analysis of discrepant results
10. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease
11. Comparison of dipyridamole and exercise stress echocardiography for detection of coronary artery disease: A meta-analysis of seven studies involving 467 patients
12. The comparable diagnostic accuracy of dobutamine and dipyridamole stress echocardiography: A meta-analysis
13. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single tomography
14. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease
15. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine and dipyridamole tests
16. Stress echocardiography: Comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease
17. The atropine factor in pharmacologic stress echocardiography
18. Simultaneous transesophageal two-dimensional echocardiography and atrial pacing for detecting coronary artery disease
19. Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: A new method of stress echocardiography
20. Biplane transesophageal pacing echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease
21. Ergonovine-echo test to assess the significance of chest pain at rest without ECG changes
22. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography
23. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients
24. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: A report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies
25. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
26. Comparison of the prognostic value of dipyridamole- and dobutamine-stress echocardiography in patients with known or suspected coronary artery disease
27. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with acute myocardial infarction
28. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: A large scale, multicenter trial
29. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: Feasibility, tolerability, safety, and in-hospital prognostic value
30. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction
31. Prognostic value of residual ischaemia assessed by exercise electrocardiography and dobutamine stress echocardiography in low risk patients following acute myocardial infarction
32. Dobutamine stress echocardiography for risk stratification following acute myocardial infarction
33. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography
34. Prediction of cardiac events after uncomplicated myocardial infarction by clinical variables and dobutamine stress echocardiography
35. The cost of post-myocardial infarction strategies: An operative proposal to eliminate (some) doubts
36. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction. A dobutamine stress echocardiographic study
37. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with myocardial infarction and mildly impaired left ventricular function
38. Dipyridamole stress echocardiography
39. Dobutamine stress echocardiography. Safety in diagnosing coronary artery disease
40. International stress echo complication registry: "Ad interim" results on 81 980 examinations
41. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography
42. The electrocardiographic response to maximal treadmill exercise in asymptomatic men with left bundle branch block
43. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms
44. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension
45. False positive stress tests due to undetected left ventricular hypertrophy
46. Stress echocardiography for prognostic stratification in patients with inability to exercise or uninterpretable electrocardiogram
47. Blood pressure as a cardiovascular risk factor
48. Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: A Bayesan approach
49. Thallium-201 stress imaging in hypertensive patients
50. Relation among impaired coronary flow reserve, left ventricular hypertrophy and thallium defect in hypertensive patients without obstructive coronary artery disease
51. Dipyridamole-echocardiography test in essential hypertensives with chest pain
52. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients
53. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both?
54. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
55. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test
56. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain
57. High-dose dipyridamole echocardiography test in women: Correlation with exercise-electrocardiography test and coronary arteriography
58. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women
59. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease
60. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin
61. Improved identification of coronary artery disease in patients with left bundle branch block by the use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography
62. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block
63. Thallium-201 SPECT in coronary artery disease patients with left bundle branch block
64. Comparison of exercise and adenosine technetium-99m sestamibi scintigraphy for diagnosis of coronary artery disease in patients with left bundle branch block
65. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block
66. Long-term prognostic value of clinically evident non coronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)
67. Prevalence of coexistence of coronary artery disease, peripheral arterial disease and atherothrombotic brain infarction in men and women > 62 years of age
68. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group
69. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery. A large-scale multicenter study in 509 patients
70. Assessment of cardiac risk before nonvascular surgery: Dobutamine stress echocardiography in 530 patients